Thursday, November 19, 2026
Biotech

Hims & Hers Adds Unapproved Peptide Shots to Its Menu

Hims & Hers now sells custom peptide blends even though health regulators have not approved them yet.

Telehealth giant Hims & Hers wants to sell you wellness peptides. The company rolled out several new injectable options this week. Customers can buy these blends directly online to boost energy and fight aging.

The new lineup includes sermorelin and glutathione. It also features NAD+ and vitamin B-12. Compounding pharmacies mix these treatments for patients. None of these specific products have approval from the FDA. The company admits scientists still need to study how well these blends work.

Online health platforms continue to push into trendy treatments. Buyers get fast access to popular anti-aging shots. Still, patients take on extra risk when they order drugs without official testing. Talk with your primary doctor before trying any new compounded drug.

Source: CNBC

#Biotech#Hims & Hers#FDA#Healthcare#Telehealth

More from Biotech